Haematological Cancers
Nexomics leads molecular haematology testing and offers comprehensive molecular testing for all aspects of haematological malignancy including conventional and next generation sequencing diagnostic testing and minimal residual disease monitoring.
Our test panels provide mutation testing for diagnostic, prognostic and therapeutic relevance in haematological malignancy. The Nexomics haematology laboratory also provides a consultative haematology molecular service to advise on appropriate NGS testing for haematological malignancies, augmented by a multidisciplinary meeting, which is attended by haematologists, geneticists and scientific staff where difficult patient cases are discussed.